BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7359146)

  • 1. Relation between benign course of multiple sclerosis and low-grade humoral immune response in cerebrospinal fluid.
    Stendahl-Brodin L; Link H
    J Neurol Neurosurg Psychiatry; 1980 Feb; 43(2):102-5. PubMed ID: 7359146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune complexes and the complement factors C4 and C3 in cerebrospinal fluid and serum from patients with chronic progressive multiple sclerosis.
    Jans H; Heltberg A; Zeeberg I; Kristensen JH; Fog T; Raun NE
    Acta Neurol Scand; 1984 Jan; 69(1):34-8. PubMed ID: 6702418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid complement proteins in neurological disease.
    Price P; Cuzner ML
    J Neurol Sci; 1980 Apr; 46(1):49-54. PubMed ID: 6966324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution.
    Beseler C; Vollmer T; Graner M; Yu X
    PLoS One; 2017; 12(10):e0186842. PubMed ID: 29059249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid C3 and C4 indexes in immunological disorders of the central nervous system.
    Jongen PJ; Doesburg WH; Ibrahim-Stappers JL; Lemmens WA; Hommes OR; Lamers KJ
    Acta Neurol Scand; 2000 Feb; 101(2):116-21. PubMed ID: 10685859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis.
    Walsh MJ; Tourtellotte WW
    J Exp Med; 1986 Jan; 163(1):41-53. PubMed ID: 3941297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Findings of cerebrospinal fluid in the diagnosis of multiple sclerosis].
    Drulović J; Stojsavljević N; Dujmović I; Sokić D; Mavra M; Lević Z
    Srp Arh Celok Lek; 1995; 123(7-8):191-3. PubMed ID: 17974427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High levels of C3c in the cerebrospinal fluid from amyotrophic lateral sclerosis patients.
    Annunziata P; Volpi N
    Acta Neurol Scand; 1985 Jul; 72(1):61-4. PubMed ID: 4050318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intrathecal oligoclonal and polyspecific immune response in multiple sclerosis].
    Robinson Agramonte MA; Reiber H; Dorta Contreras AJ; Hernández Díaz E
    Rev Neurol; 2001 Nov 1-15; 33(9):809-11. PubMed ID: 11784982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic basis of multiple sclerosis: HLA antigens, disease progression, and oligoclonal IgG in CSF.
    Stendahl-Brodin L; Link H; Möller E; Norrby E
    Acta Neurol Scand; 1979 Jun; 59(6):297-308. PubMed ID: 90443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and CSF findings in multiple sclerosis patients with or without IgG oligoclonal bands at isoelectric focusing examination of CSF and serum proteins.
    Rocchelli B; Poloni M; Mazzarello P; Delodovici M
    Eur Neurol; 1983; 22(1):35-42. PubMed ID: 6840140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin abnormalities in multiple sclerosis. Relation to clinical parameters: disability, duration and age of onset.
    Olsson JE; Link H; Müller R
    J Neurol Sci; 1976 Feb; 27(2):233-45. PubMed ID: 814208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual evoked responses and immunoglobulin abnormalities in the diagnosis of multiple sclerosis.
    Hutchinson M; Martin EA; Maguire P; Glynn D; Mansfield M; Feighery C
    Acta Neurol Scand; 1983 Aug; 68(2):90-5. PubMed ID: 6637392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis: use of light-chain typing to assist diagnosis.
    Jenkins MA; Cheng L; Ratnaike S
    Ann Clin Biochem; 2001 May; 38(Pt 3):235-41. PubMed ID: 11392498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of HLA DRB1 alleles with IgG oligoclonal bands and their influence on multiple sclerosis course and disability status.
    Balnytė R; Rastenytė D; Vaitkus A; Skrodenienė E; Vitkauskienė A; Ulozienė I
    Medicina (Kaunas); 2016; 52(4):217-222. PubMed ID: 27515835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid (CSF) parameters and clinical course of multiple sclerosis.
    Livrea P; Simone IL; Trojano M; Pisicchio L; Logroscino G; Rosato A
    Riv Neurol; 1987; 57(3):189-96. PubMed ID: 3672011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated antibody reactivity to measles virus NCORE protein among patients with multiple sclerosis and their healthy siblings with intrathecal oligoclonal immunoglobulin G production.
    Persson L; Longhi S; Enarsson J; Andersen O; Haghigi S; Nilsson S; Lagging M; Johansson M; Bergström T
    J Clin Virol; 2014 Sep; 61(1):107-12. PubMed ID: 25022622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of complement components in cerebral spinal fluid by radioimmunoassay in patients with multiple sclerosis.
    Yam P; Petz LD; Tourtellotte WW; Ma BI
    Clin Immunol Immunopathol; 1980 Dec; 17(4):492-505. PubMed ID: 7438567
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of agar gel electrophoresis and isoelectric focusing in multiple sclerosis and subacute sclerosing panencephalitis.
    Mattson DH; Roos RP; Arnason BG
    Ann Neurol; 1981 Jan; 9(1):34-41. PubMed ID: 6163394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of the humoral immune response in inflammatory diseases of the central nervous system.
    Felgenhauer K
    J Neurol; 1982; 228(4):223-37. PubMed ID: 6188810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.